Mannkind (MNKD) Net Cash Flow (2010 - 2026)
Mannkind (MNKD) posted quarterly Net Cash Flow of -$22.0 million for Q1 2026, down 2361.13% year-over-year from $975000.0 in Q1 2025, and up 58.01% quarter-over-quarter from -$52.5 million in Q4 2025.
Mannkind (MNKD) Net Cash Flow (2010 - 2026) Analysis & Trends
Mannkind (MNKD) has reported Net Cash Flow for 17 consecutive years, with -$22.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Cash Flow fell 2361.13% year-over-year to -$22.0 million; the TTM figure through Mar 2026 stood at $5.5 million (up 103.81% YoY), while the FY2025 annual figure was $28.6 million, up 114.92% from the prior year.
- Net Cash Flow rose to -$22.0 million in Q1 2026 per MNKD's latest filing, from -$52.5 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $155.5 million in Q4 2023 and bottomed at -$95.9 million in Q2 2024.
- Historically, Net Cash Flow has averaged -$4.2 million across 5 years, with a median of -$3.2 million in 2023.
- Annual changes were most pronounced in 2023 — Net Cash Flow surged 905.65% — and 2024, when it plunged 30543.49%.
- Mannkind's Net Cash Flow stood at $15.5 million in 2022, then soared by 905.65% to $155.5 million in 2023, then tumbled by 110.31% to -$16.0 million in 2024, then tumbled by 227.52% to -$52.5 million in 2025, then surged by 58.01% to -$22.0 million in 2026.
- Business Quant data shows MNKD's Net Cash Flow at -$22.0 million in Q1 2026, -$52.5 million in Q4 2025, and $70.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 407.41 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 17.81 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -496,000.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.14 Mn |
| 10 | Mannkind | 1.19 Bn | 1.08 Bn | 94.97 Mn | 97,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 97,000.00 |
| Jun 30, 2026 | 97,000.00 |
| Mar 31, 2026 | -22.05 Mn |
| Mar 31, 2026 | -22.05 Mn |
| Dec 31, 2025 | -52.51 Mn |
| Dec 31, 2025 | -52.51 Mn |
| Sep 30, 2025 | 70.39 Mn |
| Sep 30, 2025 | 70.39 Mn |
| Jun 30, 2025 | 9.70 Mn |
| Jun 30, 2025 | 9.70 Mn |
| Mar 31, 2025 | 975,000.00 |
| Mar 31, 2025 | 975,000.00 |
| Dec 31, 2024 | -16.03 Mn |
| Dec 31, 2024 | -16.03 Mn |
| Sep 30, 2024 | -34.27 Mn |
| Sep 30, 2024 | -34.27 Mn |
| Jun 30, 2024 | -95.90 Mn |
| Jun 30, 2024 | -95.90 Mn |
| Mar 31, 2024 | -45.21 Mn |
| Mar 31, 2024 | -45.21 Mn |